These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4028022)

  • 41. Isolation of monoclonal antibodies reactive with Marek's disease tumor-associated surface antigen (MATSA).
    Ikuta K; Ueda S; Kato S; Ono K; Osafune S; Yoshida I; Konobe T; Naito I; Naito M; Hirai K
    Biken J; 1984 Dec; 27(4):183-8. PubMed ID: 6399439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
    Carrel S; Accolla RS; Carmagnola AL; Mach JP
    Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blasts.
    Zipf TF; Lauzon GJ; Longenecker BM
    J Immunol; 1983 Dec; 131(6):3064-72. PubMed ID: 6358359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
    Masuko T; Yagita H; Hashimoto Y
    J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.
    Lindmo T; Boven E; Mitchell JB; Morstyn G; Bunn PA
    Cancer Res; 1985 Oct; 45(10):5080-7. PubMed ID: 4027987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proportional absorption. A method for determination of the relative specificity of antisera prepared against cells.
    Reif AE; Robinson CM
    Immunology; 1975 Jan; 28(1):199-205. PubMed ID: 1090519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic killing of retinoblastoma cells with hematoporphyrin and light.
    Sery TW
    Cancer Res; 1979 Jan; 39(1):96-100. PubMed ID: 761202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in antigen expression on human FME melanoma cells after exposure to photoactivated hematoporphyrin derivative.
    Davies CD; Western A; Lindmo T; Moan J
    Cancer Res; 1986 Dec; 46(12 Pt 1):6068-72. PubMed ID: 3779629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demonstration of a leukemia-associated antigen (CAMAL) in peripheral blood leucocytes of bone marrow transplant patients prior to relapse.
    Levy JG; Logan PM; Whitney S; Malcolm AJ; Naiman S; Powles R; Crawford D
    Transplantation; 1985 Aug; 40(2):167-73. PubMed ID: 3895623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human antisera detecting leukemia-associated antigens on autochthonous tumor cells.
    Mann DL; Leventhal B; Halterman R
    J Natl Cancer Inst; 1975 Feb; 54(2):345-7. PubMed ID: 1113320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of a leukemia-associated antigen (CAMAL) in four myeloid leukemia cell lines.
    Shipman RC; Levy JG
    Leuk Res; 1988; 12(7):537-43. PubMed ID: 3172816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Augmentation of hematoporphyrin uptake and in vitro-growth inhibition of L1210 leukemia cells by succinylacetone.
    Ebert PS; Hess RA; Tschudy DP
    J Natl Cancer Inst; 1985 Mar; 74(3):603-8. PubMed ID: 3856064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppressor deletion therapy. Selective elimination of T suppressor cells using a hematoporphyrin-conjugated monoclonal antibody.
    Steele JK; Liu D; Stammers AT; Deal H; Whitney S; Levy JG
    Targeted Diagn Ther; 1988; 1():157-89. PubMed ID: 2980947
    [No Abstract]   [Full Text] [Related]  

  • 56. Targetted phototherapy with sensitizer-monoclonal antibody conjugate and light.
    Pogrebniak HW; Matthews W; Black C; Russo A; Mitchell JB; Smith P; Roth JA; Pass HI
    Surg Oncol; 1993; 2(1):31-42. PubMed ID: 8252191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CAMAL: a new prognostic marker for remission in acute nonlymphoblastic leukemia.
    Logan PM; Whitney S; Naiman S; Levy JG
    Leuk Res; 1988; 12(1):19-24. PubMed ID: 3282127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells.
    Steele JK; Liu D; Stammers AT; Whitney S; Levy JG
    Cancer Immunol Immunother; 1988; 26(2):125-31. PubMed ID: 2965972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A panel of monoclonal antibodies and antisera for the diagnosis of human hemoblastoses].
    Baryshnikov AIu; Tupitsyn NN; Kryzhanov MA; Blokhina NG; Kadagidze ZG
    Dokl Akad Nauk SSSR; 1985; 282(3):753-9. PubMed ID: 3839745
    [No Abstract]   [Full Text] [Related]  

  • 60. Novel method for in vitro depletion of T cells by monoclonal antibody-targeted photosensitization.
    Berki T; Németh P
    J Immunol Methods; 1998 Feb; 211(1-2):139-46. PubMed ID: 9617838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.